EyePoint Pharmaceuticals, Inc. Financial Ratios — EYPT Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-24.49	-97.26	-111.55	-118.06	33.15	-97.39	-108.05	-424.98	-567.45	-337.87	-57.58	-72.84	-39.04	-43.42	-72.19
Return on Assets (%)	-19.15	-73.36	-64.59	-68.63	23.06	-67.35	-73.5	-117.7	-78.53	-55.13	-32.9	-46.09	-26.44	-33.83	-59.29
Return on Capital (%)	- -	- -	- -	- -	33.15	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	33.04	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	86.81	83.09	77.86	79.89	89.93	91.42	93.41
EBITDA Margin (%)	-133.9	-231.25	-515.03	-364.27	27.49	-1,288.02	-235.59	-848.56	-222.23	-100.59	-142.14	-184.75	-162.12	-333.5	-768.62
Operating Margin (%)	-201.47	-294.41	-561.41	-390.67	24.17	-1,344.07	-246.4	-887.34	-235.02	-108.28	-149.64	-190.65	-163.13	-337.06	-775.98
Incremental Operating Margin (%)	- -	- -	- -	- -	86.56	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-178.17	-709.13	-560.76	-388.28	24.25	-1,339.63	-245.19	-1,795.71	-278.88	-131.82	-158.14	-246.97	-153.66	-302.22	-738.53
Profit Margin (%)	-173.78	-704.34	-555.3	-384.54	23.89	-1,330.06	-245.19	-1,795.71	-278.88	-131.82	-158.14	-246.97	-153.84	-302.43	-739.42
Net Income to Common Margin (%)	-173.78	-704.34	-555.3	-384.54	23.89	-1,330.06	-245.19	-1,795.71	-278.88	-131.82	-158.14	-246.97	-153.84	-302.43	-739.42
Effective Tax Rate (%)	- -	- -	- -	- -	1.49	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-24.49	-97.26	-111.55	-118.06	33.15	-97.39	-108.05	-424.98	-567.45	-337.87	-57.58	-72.84	-39.04	-43.42	-72.19

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	17	51	41	39	46	5	22	21
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	10	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	17	50	40	38	35	5	22	21
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	-0.69	-1.12	-1.18	-0.75	-0.6	-0.07	-0.15	-0.09
Net Debt/EBITDA	1.94	0.57	0.63	1.21	-2.62	0.73	0.95	0.85	-0.55	0.2	2.71	0.73	3.77	0.69	0.42
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	-0.66	-1.06	-1.1	-0.71	-0.58	-0.07	-0.15	-0.09
Net Debt/EBIT	1.29	0.45	0.57	1.13	-2.98	0.7	0.91	0.82	-0.52	0.19	2.57	0.71	3.75	0.68	0.42
EBITDA to Interest Expense	-511.38	-8,154	-5,518.5	-12,651	- -	- -	- -	-34.9	-7.33	-4.77	-9.55	-23.99	-59.83	-10,308.14	-7,306.82
EBITDA-CapEx/Interest Expense	-521.62	-8,559	-5,552.5	-12,899	- -	- -	- -	-35.05	-7.36	-4.82	-9.58	-24.66	-62.62	-10,597.57	-7,406.21
EBIT to Interest Expense	-769.46	-10,381	-6,015.5	-13,568	- -	- -	- -	-36.49	-7.75	-5.14	-10.05	-24.75	-60.2	-10,418.14	-7,376.79
Interest Expense	- -	- -	- -	- -	- -	- -	- -	1	6	7	5	3	1	- -	- -
Common Equity/Total Assets	79.45	66.2	47.39	65.83	72.2	66.04	71.4	16.31	11.42	20.22	70.01	53.43	74.98	80.41	84.1
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	148.1	601.69	217.39	20.84	36.62	1.84	6.5	6.79
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	59.69	85.05	67.7	17.18	24.83	1.81	6.1	6.35
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	24.15	68.69	43.95	14.59	19.57	1.38	5.22	5.71
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	148.1	607.47	221.1	21.26	47.49	1.84	6.5	6.79
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	59.69	85.87	68.86	17.53	32.2	1.81	6.1	6.35
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	24.15	69.35	44.7	14.89	25.38	1.38	5.22	5.71
Net Debt to Equity	-34.49	-33.92	-89.6	-102.75	-81.83	-73.33	-126.71	-183.68	300.23	-37.39	-77.03	-57.95	-105.61	-29.63	-33.26
Net Debt/Capital (%)	-52.66	-51.33	-861.3	3,740	-450.22	-275.02	474.4	219.5	68.11	-47.4	-315.69	-120.09	2,803.1	-38.55	-45.24
EBITDA	-7	-8	-11	-13	7	-21	-18	-25	-45	-35	-53	-76	-75	-144	-241
EBITDA-CapEx	-7	-9	-11	-13	7	-21	-18	-25	-45	-35	-53	-79	-78	-148	-244
Operating Income (Loss)	-10	-10	-12	-14	6	-22	-19	-26	-48	-37	-55	-79	-75	-146	-243

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	4.79	4.58	3.11	8.6	8.52	5.69	3.19	1.79	1.93	3.02	8.94	4.19	5.23	7.56	8.27
Current Ratio	5.04	5.02	3.77	9.1	8.91	5.88	3.35	1.84	3.62	4.24	10.05	5	5.45	7.81	8.88
Quick Ratio	4.96	4.89	3.29	8.84	8.71	5.79	3.24	1.81	2.92	3.65	9.72	4.63	5.25	7.57	8.28
CFO/Avg Current Liab	-0.8	-2.19	-2.7	-3.93	3.76	-3.87	-3.95	-1.63	-3.42	-1.09	-2.6	-2.23	0.04	-2.25	-5.58
Common Equity/Total Assets	79.45	66.2	47.39	65.83	72.2	66.04	71.4	16.31	11.42	20.22	70.01	53.43	74.98	80.41	84.1
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	148.1	601.69	217.39	20.84	36.62	1.84	6.5	6.79
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	59.69	85.05	67.7	17.18	24.83	1.81	6.1	6.35
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	24.15	68.69	43.95	14.59	19.57	1.38	5.22	5.71
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	148.1	607.47	221.1	21.26	47.49	1.84	6.5	6.79
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	59.69	85.87	68.86	17.53	32.2	1.81	6.1	6.35
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	24.15	69.35	44.7	14.89	25.38	1.38	5.22	5.71
CFO/Total Liabilities	-32.75	-129.31	-102.29	-137.74	114.42	-151.95	-383.64	-36.52	-87.71	-19.73	-63.42	-77.4	2.11	-154	-414.82
CFO/CapEx	-23.83	-22.22	-128.6	-43.03	63.96	-144.39	-139.39	-202.84	-266.19	-39.88	-321.13	-30.23	0.54	-31.15	-73.2
Altman's Z-Score	-7.07	-18.33	-24.54	-10.67	-2.44	-9.33	-18.32	-12.63	-15.04	-10.23	0.3	-4.65	5.11	0.71	10.28

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	5.08	3.9	2.74	6.24	46.65	2.92	20.4	9.8	3.47	3.31	2.66	2.45	5.64	61.29	49.87
Days Sales Outstanding	71.82	93.68	133.19	58.54	7.82	125.05	17.89	37.23	105.04	110.34	137.38	149.23	64.67	5.95	7.32
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	2.51	1.56	1.83	2.56	1.36	1.2	1
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	145.21	234.24	199.82	142.52	267.6	305.36	363.76
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	1.35	2	1.06	1.14	0.91	0.23	0.14
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	269.76	182.1	344.76	319.64	401.13	1,575.59	2,575.29
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	-19.51	162.48	-7.56	-27.89	-68.85	-1,264.27	-2,204.21
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	-40.17	-123.89	-62.44	6.72	-202.93	-299.41	-356.44
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	2	5	4	3	4	2	2
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	1	3	3	1	1	2	1
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	1	1	1	1
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	- -	- -	2	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	89	48	90	127	111	97	67	155	170	119	415	119	1,133	509	1,513
- Cash & Cash Equivalents	13	5	7	15	19	15	17	39	22	45	179	96	281	100	102
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	17	51	41	39	46	5	22	21
Enterprise Value	65	33	80	109	82	68	50	134	198	115	243	20	807	160	1,228
Total Capital	37	14	8	15	23	21	13	29	59	60	224	142	271	358	327
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	59.69	85.87	68.86	17.53	32.2	1.81	6.1	6.35
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	0.13	0.26	0.36	0.16	2.23	0.01	0.14	0.02
EV/Sales	13.03	9.5	37.28	31.35	3.1	41.8	6.69	45.09	9.72	3.35	6.57	0.5	17.54	3.69	39.14
EV/EBITDA	- -	- -	- -	- -	11.28	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	12.83	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	8	- -	- -	- -	- -	- -	- -	- -	258.44	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	7.87	- -	- -	- -	- -	- -	- -	- -	122.19	- -	- -
Diluted Market Cap	83	48	89	119	115	89	60	96	162	84	352	131	899	419	1,338
Diluted Enterprise Value	71	43	82	104	96	74	44	75	190	81	213	81	623	342	1,257
EV per Share	31.17	16.1	34.29	37.16	28	19.82	12.81	17.92	18.09	6.36	7.16	0.6	16.46	2.34	14.83
TTM Sales	5	4	2	3	27	2	8	3	20	34	37	41	46	43	31
TTM EBITDA	-7	-8	-11	-13	7	-21	-18	-25	-45	-35	-53	-76	-75	-144	-241
TTM Operating Income	-10	-10	-12	-14	6	-22	-19	-26	-48	-37	-55	-79	-75	-146	-243
TTM Cash Flow to Firm	-3	-9	-9	-11	10	-16	-20	-21	-51	-7	-45	-62	3	-126	-240
TTM Free Cash Flow to Firm	-3	-9	-9	-10	10	-16	-20	-21	-50	-7	-44	-60	7	-122	-237

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	06/30/2011	06/30/2012	06/30/2013	06/30/2014	06/30/2015	06/30/2016	06/30/2017	06/30/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-27.47	-5.59	-10.28	-11.43	11.03	-5.52	-2.97	-4.41	-2.86	-6	-7.05	-2.08	167.8	-3.43	-5.65
EV/EBIT	- -	- -	- -	- -	12.83	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	65	33	80	109	82	68	50	134	198	115	243	20	807	160	1,228
Low Price	31.6	10.2	11.7	22.8	34.5	23.7	15	9.3	11.9	3.5	6.87	2.19	2.21	6.9	3.91
EV/Sales	13.03	9.5	37.28	31.35	3.1	41.8	6.69	45.09	9.72	3.35	6.57	0.5	17.54	3.69	39.14
EV/EBITDA	- -	- -	- -	- -	11.28	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	17.45	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-9.88	-2.24	-3.92	-7.74	19.3	-5.16	-4.48	-1.22	-3.38	-2.42	-5.4	-3.16	-4.38	-6.06	-3.15
Price/Earnings High	-16.31	-4.38	-7.8	-11.51	22.87	-8.53	-8.13	-2.5	-5.18	-5.94	-10.58	-5.26	-13.53	-13.33	-6.03
Price/Earnings Low	-7.14	-0.85	-2.27	-4.69	15.97	-3.48	-2.87	-0.81	-2.19	-0.99	-3.38	-0.8	-1.21	-2.97	-1.23
Price/Book Value	2.37	3.52	11.71	8.52	4.75	4.63	5.05	13.26	20.36	6.44	2.25	1.24	4.26	1.51	4.94
Price/Book Value Average	2.42	4.08	6.12	7.4	5.25	5.75	6.91	8.91	24.19	8.36	2.02	3.07	1.47	2.86	2.7
Price/Book Value High	4	7.98	12.19	10.99	6.22	9.51	12.54	18.36	37.04	20.55	3.95	5.1	4.53	6.29	5.17
Price/Book Value Low	1.75	1.56	3.54	4.48	4.34	3.88	4.43	5.93	15.63	3.42	1.26	0.77	0.41	1.4	1.06
Price/Tangible Book Value	5.6	5.11	21.11	10.46	5.17	4.89	5.19	-7.88	-8.77	-17.9	2.57	1.24	4.26	1.51	4.94
Price/Tangible Book Value Average	5.72	5.91	11.04	9.08	5.72	6.07	7.1	-5.29	-10.42	-23.25	2.3	3.07	1.47	2.86	2.7
Price/Tangible Book Value High	9.44	11.56	21.99	13.49	6.78	10.04	12.89	-10.91	-15.96	-57.13	4.51	5.1	4.53	6.29	5.17
Price/Tangible Book Value Low	4.13	2.25	6.38	5.49	4.73	4.09	4.55	-3.52	-6.73	-9.52	1.44	0.77	0.41	1.4	1.06
Price/Sales	16.8	13.62	41.61	34.3	4.17	55.24	8.02	32.47	7.94	2.45	9.53	3.15	19.54	9.69	42.66
Price/Sales Average	17.16	15.78	21.75	29.78	4.61	68.64	10.97	21.82	9.43	3.19	8.54	7.81	6.75	18.32	23.27
Price/Sales High	28.34	30.84	43.34	44.25	5.46	113.41	19.92	44.96	14.44	7.83	16.74	12.99	20.81	40.32	44.62
Price/Sales Low	12.4	6.01	12.58	18.02	3.82	46.26	7.03	14.52	6.1	1.3	5.35	1.97	1.87	8.98	9.13
Price/Cash Flow	-26.31	-5.34	-10.2	-11.16	10.76	-5.48	-2.95	-4.39	-2.85	-5.85	-7.03	-2.01	479.5	-3.32	-5.57
Price/Cash Flow Average	-26.88	-6.18	-5.33	-9.69	11.9	-6.81	-4.04	-2.95	-3.39	-7.6	-6.29	-4.98	165.56	-6.28	-3.04
Price/Cash Flow High	-44.39	-12.08	-10.62	-14.4	14.09	-11.26	-7.33	-6.08	-5.19	-18.67	-12.34	-8.27	510.84	-13.82	-5.83
Price/Cash Flow Low	-19.43	-2.36	-3.08	-5.86	9.84	-4.59	-2.59	-1.96	-2.19	-3.11	-3.94	-1.26	45.85	-3.08	-1.19
Price/Free Cash Flow Average	-28.06	-6.47	-5.37	-9.92	12.2	-6.86	-4.07	-2.96	-3.4	-7.8	-6.31	-5.15	57.94	-6.49	-3.08
Price/Free Cash Flow High	-46.33	-12.65	-10.7	-14.74	14.45	-11.34	-7.38	-6.11	-5.21	-19.15	-12.38	-8.56	178.76	-14.28	-5.91
Price/Free Cash Flow Low	-20.28	-2.47	-3.11	-6	10.09	-4.63	-2.61	-1.97	-2.2	-3.19	-3.96	-1.3	16.05	-3.18	-1.21
EV/Sales Average	15.67	14.47	18.77	27.38	3.9	64.72	9.98	27.92	11.29	4.39	6.29	5.93	2.5	20.41	23.73
EV/Sales High	27.57	29.54	40.59	42.83	4.75	113.11	19.95	65.22	16.55	10.95	15.96	10.66	20.23	47.09	47.87
EV/Sales Low	10.6	4.71	9.5	14.82	3.1	40.54	5.59	16.15	7.79	1.73	2.53	0.6	- -	9.09	7.74
EV/EBITDA Average	-11.7	-6.26	-3.65	-7.52	14.18	-5.02	-4.24	-3.29	-5.08	-4.36	-4.43	-3.21	-1.54	-6.12	-3.09
EV/EBITDA High	-20.59	-12.78	-7.88	-11.76	17.28	-8.78	-8.47	-7.69	-7.45	-10.88	-11.23	-5.77	-12.48	-14.12	-6.23
EV/EBITDA Low	-7.92	-2.04	-1.84	-4.07	11.28	-3.15	-2.37	-1.9	-3.5	-1.72	-1.78	-0.32	2.25	-2.72	-1.01
EV/EBIT Average	-7.78	-4.92	-3.34	-7.01	16.12	-4.82	-4.05	-3.15	-4.8	-4.05	-4.2	-3.11	-1.53	-6.06	-3.06
EV/EBIT High	-13.69	-10.03	-7.23	-10.96	19.65	-8.42	-8.09	-7.35	-7.04	-10.11	-10.67	-5.59	-12.4	-13.97	-6.17
EV/EBIT Low	-5.26	-1.6	-1.69	-3.79	12.83	-3.02	-2.27	-1.82	-3.31	-1.6	-1.69	-0.31	2.24	-2.7	-1
Last Price	42.8	23.1	38.7	43.4	37.7	28.3	17.1	20.8	15.5	6.58	12.24	3.5	23.11	7.45	18.27
High Price	72.2	52.3	40.3	56	49.4	58.1	42.5	28.8	28.2	21	21.5	14.41	24.62	30.99	19.11
Enterprise Value Average	78	51	40	95	104	105	75	83	230	151	232	246	115	883	744
Enterprise Value High	137	104	87	149	126	183	150	193	337	377	590	441	931	2,038	1,502
Enterprise Value Low	53	17	20	51	82	66	42	48	159	60	94	25	-168	393	243

Shares Outstanding	2	2	2	3	3	3	4	7	11	18	34	34	49	68	83
Diluted Weighted Avg Shares	2	2	2	3	3	3	4	5	10	13	29	37	39	56	73
Basic Weighted Avg Shares	2	2	2	3	3	3	4	5	10	13	29	37	39	56	73
Revenue per Share	2.55	1.7	0.93	1.27	9.04	0.51	2.13	0.64	1.95	2.68	1.28	1.11	1.18	0.77	0.43
EBITDA per Share	-3.41	-3.92	-4.79	-4.61	2.49	-6.6	-5.03	-5.44	-4.34	-2.7	-1.83	-2.05	-1.92	-2.56	-3.29
Operating Income per Share	-5.13	-4.99	-5.22	-4.94	2.19	-6.89	-5.26	-5.68	-4.59	-2.91	-1.92	-2.12	-1.93	-2.59	-3.32
Basic EPS, GAAP	-4.43	-11.95	-5.16	-4.87	2.16	-6.81	-5.23	-11.5	-5.44	-3.54	-2.03	-2.74	-1.82	-2.32	-3.17
Basic EPS from Cont Ops	-4.43	-11.95	-5.16	-4.87	2.16	-6.81	-5.23	-11.5	-5.44	-3.54	-2.03	-2.74	-1.82	-2.32	-3.17
Diluted EPS, GAAP	-4.43	-11.95	-5.16	-4.87	2.08	-6.81	-5.23	-11.5	-5.44	-3.54	-2.03	-2.74	-1.82	-2.32	-3.17
Diluted EPS from Cont Ops	-4.43	-11.95	-5.16	-4.87	2.08	-6.81	-5.23	-11.5	-5.44	-3.54	-2.03	-2.74	-1.82	-2.32	-3.17
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.63	-4.33	-3.79	-3.89	3.51	-5.16	-5.8	-4.74	-5.44	-1.12	-1.74	-1.74	0.05	-2.24	-3.28
Free Cash Flow per Basic Share	-1.69	-4.52	-3.82	-3.98	3.45	-5.2	-5.84	-4.76	-5.46	-1.15	-1.75	-1.8	-0.04	-2.31	-3.32
Cash & Equivalents per Share	11.63	7	4.41	6.24	9.7	8.48	4.29	5.2	2.03	2.48	6.24	4.24	6.75	5.43	3.7
Book Value per Share	18.04	6.55	3.31	5.09	7.94	6.11	3.39	1.57	0.76	1.02	5.44	2.83	5.43	4.93	3.7
Tangible Book Value per Share	7.65	4.52	1.83	4.15	7.29	5.79	3.3	-2.64	-1.77	-0.37	4.77	2.83	5.43	4.93	3.7

EyePoint Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)